Genetically Modified T Cells Treating Malignant Tumors

计划入组 100 人 · 首次发布于 2024 年 7 月 23 日

CAR-T Cells in the Treatment of Malignant Hematological Tumors

计划入组 20 人 · 首次发布于 2022 年 11 月 17 日

CAR T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR

计划入组 10 人 · 首次发布于 2015 年 1 月 6 日

Multiple Antigen Specific Endogenously Derived T Cells (Technical University of Denmark)

Activated T cells Therapy(Kairos)

Anti-MUC1 CAR T cell/PD-1 knockout engineered T cell therapy

STEM CELLS ARABIA

Jordan

Personalized Stem Cells, Inc.

United States

KLSMC Stem Cells, Inc.

FDA Approves Novel Therapies for Synovial Sarcoma, Cutaneous T-Cell Lymphoma, and Subcutaneous Atezolizumab

FDA Approves Reformulated Denileukin Diftitox (Lymphir) for Relapsed/Refractory Cutaneous T-Cell Lymphoma

HyBryte™: A Promising Photodynamic Therapy for Cutaneous T-Cell Lymphoma (CTCL)